BUSILVEX 6 MG/ML INJ FL 10 ML
(Busulfan) - Maladie rare sans désignation orpheline
*Followed by cyclophosphamide (BuCy2), conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in adult patients when the combination is considered the best available option.
*Following fludarabine (FB), conditioning treatment prior to haematopoietic progenitor cell transplantation in adult patients who are candidates for a reduced-intensity conditioning (RIC) regimen.
*Followed by cyclophosphamide (BuCy4) or melphalan (BuMel), conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.